Infusion Market Data by State
Where infusion demand is growing, how many centers already serve it, and how many nursing jobs are open, for every state. Built for owners deciding where to open or grow.
- Medicare paid doctors and clinics for infusion drugs in 2024
- $6.0B
- growth since 2022, from $5.1B
- +19%
- infusion centers registered with CMS
- 1,806
- open infusion nursing jobs
- 1,221
Medicare claims 2022 to 2024, the latest CMS has released (published May 2026). Centers and jobs as of November 11, 2026.
Look Up a State
Kansas
Fastest growth of 29 states- infusion drug payments, 2024
- $118M
- since 2022
- +38%
- infusion centers, $8M each
- 15
- open infusion jobs
- 15
Top Infusion Therapies in Kansas
- 1Pembrolizumab (Keytruda)
- 2Denosumab (Prolia)
- 3Daratumumab (Darzalex Faspro)
623 doctors and clinics in Kansas billed Medicare for infusion services in 2024.
Where Demand Is Growing Fastest
Growth in Medicare infusion drug payments, 2022 to 2024, for the 29 states with at least $50M in 2022. The national rate was 19%.
Payments grew while infusion visits fell, so each infusion carries more drug spending than it did in 2022. Fast growth with few centers is the pattern worth a closer look.
- Kansas38%
- California33%
- Pennsylvania32%
- Minnesota27%
- Iowa27%
- Texas26%
- Colorado25%
- Arizona24%
- Maryland23%
- Oklahoma23%
Every State
| State | Payments 2024 | Growth | Providers | Centers | Per center | Open jobs |
|---|---|---|---|---|---|---|
| Florida | $749M | +18% | 4,808 | 237 | $3M | 88 |
| California | $542M | +33% | 5,320 | 139 | $4M | 90 |
| Texas | $504M | +26% | 6,311 | 240 | $2M | 73 |
| Illinois | $256M | +14% | 1,604 | 39 | $7M | 74 |
| Virginia | $255M | +11% | 1,494 | 42 | $6M | 15 |
| Pennsylvania | $251M | +32% | 1,558 | 33 | $8M | 37 |
| Maryland | $237M | +23% | 966 | 40 | $6M | 22 |
| New York | $228M | +10% | 2,478 | 53 | $4M | 108 |
| Arizona | $221M | +24% | 1,558 | 71 | $3M | 45 |
| Tennessee | $197M | +20% | 3,260 | 36 | $5M | 37 |
| South Carolina | $191M | +18% | 1,682 | 32 | $6M | 41 |
| New Jersey | $172M | +17% | 1,487 | 45 | $4M | 33 |
| North Carolina | $157M | -2% | 2,679 | 39 | $4M | 18 |
| Georgia | $143M | +23% | 3,061 | 69 | $2M | 35 |
| Alabama | $141M | +12% | 2,546 | 37 | $4M | 16 |
Growth is shown only for states with at least $50M in Medicare infusion drug payments in 2022, so one practice cannot top the list. Per center is shown only for states with 5 or more registered infusion centers. Growth at or above the national +19% is in blue.
How to Read This
- Payments show how much infusion therapy Medicare patients already get in a state. Bigger is a deeper market, not an open one.
- Growth shows where demand is rising. Fast growth with few centers is the pattern worth a closer look.
- Per center is a rough demand-to-supply ratio. A high number can mean patients are still going to hospitals or driving far.
- Open jobs show who is already expanding there, and how hard it will be to hire nurses.
- State totals hide big differences between metro areas. A site decision needs county or ZIP level data, referral concentration and drive times. See how to choose your next infusion site.
The Greyfield Infusion Report 2026
Our yearly report on the infusion market: where Medicare infusion spending is growing, which therapies drive it, and which states have the most demand for every infusion center. Free PDF.
Get the Report
Method and sources
Medicare figures come from the CMS Medicare Physician and Other Practitioners by Provider and Service files for 2022, 2023, 2024, totaled by state. Payments are services times the average Medicare payment.
Part B drug codes with at least half their payments going to providers who also bill infusion administration codes that year; skin substitutes and vaccines excluded.
Doctors' and clinics' Part B claims only. Hospital outpatient facility claims and home infusion (Part D/DME) are not in this file.
Infusion centers are organizations in the CMS NPI Registry with the ambulatory infusion therapy clinic taxonomy, minus IV hydration spas, as of November 8, 2026. Open jobs are infusion jobs listed on InfusionJobs as of November 11, 2026. Both come from InfusionJobs, a job board Greyfield Data runs.
Only state totals are shown. No individual doctors, clinics or patients appear on this page.
Questions
- Which states have the fastest-growing infusion demand?
- By Medicare infusion drug payments to doctors and clinics, Kansas (+38%), California (+33%) and Pennsylvania (+32%) grew fastest from 2022 to 2024, among states with at least $50M in 2022.
- How much does Medicare pay for infusion drugs?
- In 2024, Medicare Part B paid doctors and clinics $6.0B for infusion drugs, +19% since 2022. Hospital outpatient departments and home infusion are billed separately and are not included, so total infusion spending is higher.
- How do you measure infusion demand in a market?
- Start with what Medicare pays for the infusion drugs given in the area and how fast it is growing, then compare it with how many infusion centers already serve it. For a specific site, add referral concentration, drive times and payer mix.
- Where does this infusion market data come from?
- CMS Medicare Physician and Other Practitioners by Provider and Service files, totaled by state, plus the CMS NPI Registry for infusion centers and open job counts from InfusionJobs. No individual providers are shown.
- Can I get this data for my own market?
- Yes. The same CMS files go down to county, ZIP code and practice level, which is how a site selection or referral analysis is built. Greyfield Data builds these for infusion groups.
For nurses, the same data drives InfusionJobs' guide to where infusion work is growing.
Related tools
Want this for your own market?
We build county, ZIP and practice-level market views from the same CMS files for infusion groups choosing their next site.